Livewort Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 50.93%
- Profit Growth 35.82%
- Ebitda 67.83%
- Net Worth 52.77%
- Total Assets 23.40%
About Livewort Labs
Livewort Labs Private Limited (LLPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 07 October 2019 (Five years and four months 21 days old ). Its registered office is in Chandigarh, Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Mittal and Sanjay Garg serve as directors at the Company.
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909CH2019PTC042723
- Company No.
042723
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Livewort Labs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Mittal  | Director | 07-Oct-2019 | Current |
| Sanjay Garg | Director | 07-Oct-2019 | Current |
Financial Performance of Livewort Labs.
Livewort Labs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 50.93% increase. The company also saw a substantial improvement in profitability, with a 35.82% increase in profit. The company's net worth Soared by an impressive increase of 52.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Livewort Labs?
Unlock access to Livewort Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Jydem Bio Pharma Private LimitedSuresh Mittal is a mutual person
Erika Remedies Private LimitedSuresh Mittal and Sanjay Garg are mutual person
Dolphar Life Care Private LimitedSanjay Garg is a mutual person
Dolvis Bio Pharma Private LimitedSanjay Garg is a mutual person
Oraxon Bio Pharma Private LimitedSuresh Mittal is a mutual person
- Vlead Labs Private Limited
Suresh Mittal and Sanjay Garg are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Livewort Labs?
Unlock and access historical data on people associated with Livewort Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Livewort Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Livewort Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.